Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...